Search for: "MERCK & CO., INC. " Results 201 - 220 of 664
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
15 Apr 2013, 7:10 am by Lawrence B. Ebert
See In re Merck & Co., Inc., 800 F.2d 1091, 1097 (Fed. [read post]
28 Jan 2013, 4:35 am by Rebecca Tushnet
Johnson & Johnson–Merck Consumer Pharmaceuticals Co., 290 F.3d 578 (3d Cir. 2002). [read post]
23 Jan 2013, 2:03 pm by Jeffrey P. Hermes
I have no connection to Merck & Co., nor would I have any reason to believe that someone had previously searched for me in connection with Merck. [read post]
23 Jan 2013, 2:03 pm by Jeffrey P. Hermes
I have no connection to Merck & Co., nor would I have any reason to believe that someone had previously searched for me in connection with Merck. [read post]
16 Jan 2013, 3:41 pm
Women are continuing to file defective medical device/drug injury cases against Merck & Co. [read post]
27 Dec 2012, 7:42 am by Lawrence B. Ebert
See In re Keller, 642 F.2d 413, 426 (CCPA 1981)(finding that one cannot show nonobviousness by attacking references individually where the rejections are based on combinations of references); see also In re Merck & Co., Inc., 800 F.2d 1091, 1097 (Fed. [read post]
27 Dec 2012, 7:24 am by Lawrence B. Ebert
See id. at 426; In re Merck & Co., Inc., 800 F.2d 1091, 1097 (Fed. [read post]
24 Nov 2012, 12:38 pm by Schachtman
  As I noted in “Confusion Over Causation in Texas” (Aug. 27, 2011), the Texas Supreme Court managed to confuse general and specific causation concepts in its decision in Merck & Co. v. [read post]
21 Nov 2012, 5:00 am by Bexis
Merck & Co.,, No. 267003, 2006 WL 1628516, at *3 (Mich. [read post]
5 Nov 2012, 11:30 am
Zambri, founding member and partner The AP (11/2) reported Merck & Co. [read post]
24 Oct 2012, 11:00 am by Sheppard Mullin
” [3] When the terminal disclaimer was filed on July 2, 2010, the application that issued as the ‘176 patent and the ‘789 patent were also owned by Email Link and Online News Link. [4] Merck & Co., Inc. v. [read post]
28 Sep 2012, 11:15 am by Todd M. Nosher
Earlier this month, we reported that Merck & Co. had filed a petition for a Writ of Certiorari seeking to challenge the Third Circuit’s decision in In re K-Dur Antitrust Litig. holding that reverse payments are prima facie evidence of an antitrust violation. [read post]